Annual FCF
-$6.73 M
+$57.99 M+89.60%
December 31, 2024
Summary
- As of March 14, 2025, TXG annual free cash flow is -$6.73 million, with the most recent change of +$57.99 million (+89.60%) on December 31, 2024.
- During the last 3 years, TXG annual FCF has risen by +$115.92 million (+94.51%).
- TXG annual FCF is now at all-time high.
Performance
TXG Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$9.46 M
-$27.22 M-153.31%
December 31, 2024
Summary
- As of March 14, 2025, TXG quarterly free cash flow is -$9.46 million, with the most recent change of -$27.22 million (-153.31%) on December 31, 2024.
- Over the past year, TXG quarterly FCF has dropped by -$27.22 million (-153.31%).
- TXG quarterly FCF is now -142.42% below its all-time high of $22.31 million, reached on December 31, 2023.
Performance
TXG Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$6.73 M
-$31.77 M-126.87%
December 31, 2024
Summary
- As of March 14, 2025, TXG TTM free cash flow is -$6.73 million, with the most recent change of -$31.77 million (-126.87%) on December 31, 2024.
- Over the past year, TXG TTM FCF has dropped by -$31.77 million (-126.87%).
- TXG TTM FCF is now -126.87% below its all-time high of $25.04 million, reached on September 30, 2024.
Performance
TXG TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
TXG Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +89.6% | -153.3% | -126.9% |
| 3 y3 years | +94.5% | -153.3% | -126.9% |
| 5 y5 years | +17.3% | -153.3% | -126.9% |
TXG Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.9% | -142.4% | +80.7% | -126.9% | +95.9% |
| 5 y | 5-year | at high | +97.4% | -142.4% | +93.8% | -126.9% | +97.7% |
| alltime | all time | at high | +97.4% | -142.4% | +93.8% | -126.9% | +97.7% |
10x Genomics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$6.73 M(-89.6%) | -$9.46 M(-153.3%) | -$6.73 M(-126.9%) |
| Sep 2024 | - | $17.75 M(+390.7%) | $25.04 M(-174.9%) |
| Jun 2024 | - | $3.62 M(-119.4%) | -$33.45 M(-54.8%) |
| Mar 2024 | - | -$18.64 M(-183.5%) | -$73.95 M(+14.3%) |
| Dec 2023 | -$64.72 M(-60.8%) | $22.31 M(-154.8%) | -$64.72 M(-42.7%) |
| Sep 2023 | - | -$40.74 M(+10.5%) | -$113.04 M(-4.6%) |
| Jun 2023 | - | -$36.88 M(+292.1%) | -$118.44 M(-5.8%) |
| Mar 2023 | - | -$9.41 M(-63.8%) | -$125.74 M(-23.9%) |
| Dec 2022 | -$165.27 M(+34.7%) | -$26.01 M(-43.6%) | -$165.27 M(+2.6%) |
| Sep 2022 | - | -$46.14 M(+4.4%) | -$161.07 M(-0.2%) |
| Jun 2022 | - | -$44.18 M(-9.7%) | -$161.38 M(+25.4%) |
| Mar 2022 | - | -$48.94 M(+124.4%) | -$128.64 M(+4.9%) |
| Dec 2021 | -$122.65 M | -$21.81 M(-53.0%) | -$122.65 M(-51.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$46.44 M(+305.7%) | -$253.28 M(-4.0%) |
| Jun 2021 | - | -$11.45 M(-73.3%) | -$263.77 M(-8.6%) |
| Mar 2021 | - | -$42.95 M(-71.8%) | -$288.58 M(+12.6%) |
| Dec 2020 | -$256.29 M(+3048.6%) | -$152.44 M(+167.7%) | -$256.29 M(+147.1%) |
| Sep 2020 | - | -$56.94 M(+57.0%) | -$103.73 M(+125.8%) |
| Jun 2020 | - | -$36.26 M(+240.3%) | -$45.95 M(+145.1%) |
| Mar 2020 | - | -$10.65 M(-9053.8%) | -$18.75 M(+130.3%) |
| Dec 2019 | -$8.14 M(-90.2%) | $119.00 K(-86.0%) | -$8.14 M(-1.4%) |
| Sep 2019 | - | $848.00 K(-109.4%) | -$8.26 M(-9.3%) |
| Jun 2019 | - | -$9.06 M(>+9900.0%) | -$9.11 M(>+9900.0%) |
| Mar 2019 | - | -$49.00 K | -$49.00 K |
| Dec 2018 | -$83.12 M(+475.0%) | - | - |
| Dec 2017 | -$14.46 M | - | - |
FAQ
- What is 10x Genomics annual free cash flow?
- What is the all time high annual FCF for 10x Genomics?
- What is 10x Genomics annual FCF year-on-year change?
- What is 10x Genomics quarterly free cash flow?
- What is the all time high quarterly FCF for 10x Genomics?
- What is 10x Genomics quarterly FCF year-on-year change?
- What is 10x Genomics TTM free cash flow?
- What is the all time high TTM FCF for 10x Genomics?
- What is 10x Genomics TTM FCF year-on-year change?
What is 10x Genomics annual free cash flow?
The current annual FCF of TXG is -$6.73 M
What is the all time high annual FCF for 10x Genomics?
10x Genomics all-time high annual free cash flow is -$6.73 M
What is 10x Genomics annual FCF year-on-year change?
Over the past year, TXG annual free cash flow has changed by +$57.99 M (+89.60%)
What is 10x Genomics quarterly free cash flow?
The current quarterly FCF of TXG is -$9.46 M
What is the all time high quarterly FCF for 10x Genomics?
10x Genomics all-time high quarterly free cash flow is $22.31 M
What is 10x Genomics quarterly FCF year-on-year change?
Over the past year, TXG quarterly free cash flow has changed by -$27.22 M (-153.31%)
What is 10x Genomics TTM free cash flow?
The current TTM FCF of TXG is -$6.73 M
What is the all time high TTM FCF for 10x Genomics?
10x Genomics all-time high TTM free cash flow is $25.04 M
What is 10x Genomics TTM FCF year-on-year change?
Over the past year, TXG TTM free cash flow has changed by -$31.77 M (-126.87%)